Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
Omadacycline
Omadacycline
PTK-0796
Nuzyra
Omedacycline
Parent topics
Tetracycline antibiotics
This topic
Recent activity
You must be
signed in
to add and move topics and links.
Changes in Therapy Recommendations in the 2019 ATS/IDSA Guidelines for Community-Acquired Pneumonia
https://www.contagionlive.com/news/changes-in-therapy-recommendations-in-the-2019-atsidsa-guidelines-for-communityacquired-pneumonia
Amoxicillin
Ceftaroline
Cefuroxime
Lefamulin
Omadacycline
Sulbactam
IDWeek 2019 News Network: Areas of Improvement for CAP Guidelines
https://www.contagionlive.com/insights/idweek-news-network-2019/idweek-2019-news-network-areas-of-improvement-for-cap-guidelines
Lefamulin
Omadacycline
OASIS Pooled Results: Omadacycline Safe and Efficacious in IVDU and non-IVDU
https://www.contagionlive.com/news/oasis-pooled-results-omadacycline-safe-and-efficacious-in-ivdu-and-nonivdu
Omadacycline
Science world mourns passing of prominent voice on antibiotic resistance | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/09/science-world-mourns-passing-prominent-voice-antibiotic-resistance
Antibiotic resistance and the use of antibiotics in farm animals
Omadacycline
Sarecycline
Stuart B Levy
Stewardship / Resistance Scan for Aug 30, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/08/stewardship-resistance-scan-aug-30-2019
2019-08 FDA warning about duodenoscopes
Omadacycline
The Lancet Infectious Diseases Publishes Results from Paratek’s Phase 3 Oral only Dosing Study of NUZYRA® (omadacycline) for Skin Infections Nasdaq:PRTK
https://www.globenewswire.com/news-release/2019/08/30/1909018/0/en/The-Lancet-Infectious-Diseases-Publishes-Results-from-Paratek-s-Phase-3-Oral-only-Dosing-Study-of-NUZYRA-omadacycline-for-Skin-Infections.html
Omadacycline